1-6 of 6
Roland Schnell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)

Free
Brief Report
Holger Schulz, Ute Rehwald, Franck Morschhauser, Thomas Elter, Christoph Driessen, Thomas Rüdiger, Peter Borchmann, Roland Schnell, Volker Diehl, Andreas Engert, Marcel Reiser
Journal: Blood
Blood (2008) 111 (1): 109–111.
https://doi.org/10.1182/blood-2007-03-078725
Published: 2008
Includes: Supplemental data
Journal Articles

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

Free
Elke Pogge von Strandmann, Hinrich P. Hansen, Katrin S. Reiners, Roland Schnell, Peter Borchmann, Sabine Merkert, Venkateswara R. Simhadri, Andreas Draube, Marcel Reiser, Ingvill Purr, Michael Hallek, Andreas Engert
Journal: Blood
Blood (2006) 107 (5): 1955–1962.
https://doi.org/10.1182/blood-2005-05-2177
Published: 2006
Journal Articles

The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma

Free
Peter Borchmann, John F. Treml, Hinrich Hansen, Claudia Gottstein, Roland Schnell, Oliver Staak, Hui-fen Zhang, Thomas Davis, Tibor Keler, Volker Diehl, Robert F. Graziano, Andreas Engert
Journal: Blood
Blood (2003) 102 (10): 3737–3742.
https://doi.org/10.1182/blood-2003-02-0515
Published: 2003
Journal Articles

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma

Free
Clinical Trials & Observations
Peter Borchmann, Roland Schnell, Irene Fuss, Oliver Manzke, Thomas Davis, Lionel D. Lewis, Detlev Behnke, Claudia Wickenhauser, Petra Schiller, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2002) 100 (9): 3101–3107.
https://doi.org/10.1182/blood-2001-12-0295
Published: 2002
Journal Articles

Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice

Free
Stefan Barth, Michael Huhn, Bärbel Matthey, Samir Tawadros, Roland Schnell, Timo Schinköthe, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2000) 95 (12): 3909–3914.
https://doi.org/10.1182/blood.V95.12.3909
Published: 2000
Journal Articles

A Phase-I Study of an Anti-CD25 Ricin A-Chain Immunotoxin (RFT5-SMPT-dgA) in Patients With Refractory Hodgkin's Lymphoma

Free
Andreas Engert, Volker Diehl, Roland Schnell, Andrea Radszuhn, Maria-Theresia Hatwig, Silke Drillich, Gisela Schön, Heribert Bohlen, Hans Tesch, Martin-Leo Hansmann, Stefan Barth, John Schindler, Victor Ghetie, Jonathan Uhr, Ellen Vitetta
Journal: Blood
Blood (1997) 89 (2): 403–410.
https://doi.org/10.1182/blood.V89.2.403
Published: 1997